Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AEXA
American Exceptionalism Acquisition
$11.28
-0.2%
$11.29
$10.49
$11.91
$556.93MN/A110,228 shs97,009 shs
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
$7.75
+3.9%
$8.50
$7.00
$14.87
$620.83M0.29362,754 shs227,617 shs
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
$9.00
-0.1%
$7.55
$3.35
$9.17
$599.98M2.5607,011 shs901,248 shs
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
$10.62
0.0%
$10.60
$10.19
$11.63
$148.68M0.0813,137 shs10,383 shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AEXA
American Exceptionalism Acquisition
-0.47%+0.50%-2.98%+1.45%+1,128,199,900.00%
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
+3.89%-0.77%-4.08%-14.74%+774,999,900.00%
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
-0.11%+4.53%+17.19%+48.51%+152.81%
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
-0.04%+0.15%+0.15%+1.30%+1.59%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AEXA
American Exceptionalism Acquisition
$11.28
-0.2%
$11.29
$10.49
$11.91
$556.93MN/A110,228 shs97,009 shs
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
$7.75
+3.9%
$8.50
$7.00
$14.87
$620.83M0.29362,754 shs227,617 shs
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
$9.00
-0.1%
$7.55
$3.35
$9.17
$599.98M2.5607,011 shs901,248 shs
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
$10.62
0.0%
$10.60
$10.19
$11.63
$148.68M0.0813,137 shs10,383 shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AEXA
American Exceptionalism Acquisition
-0.47%+0.50%-2.98%+1.45%+1,128,199,900.00%
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
+3.89%-0.77%-4.08%-14.74%+774,999,900.00%
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
-0.11%+4.53%+17.19%+48.51%+152.81%
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
-0.04%+0.15%+0.15%+1.30%+1.59%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AEXA
American Exceptionalism Acquisition
1.00
SellN/AN/A
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
2.60
Moderate Buy$25.00222.58% Upside
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
2.00
Hold$7.40-17.78% Downside
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest RANG, BBOT, ILPT, and AEXA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/8/2026
AEXA
American Exceptionalism Acquisition
UpgradeSell (E)Sell (E+)
5/28/2026
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
DowngradeSell (D)Sell (D-)
5/11/2026
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
Initiated CoverageBuy$23.00
5/11/2026
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
Initiated CoverageBuy$23.00
5/1/2026
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
DowngradeStrong-BuyHold
4/27/2026
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
Reiterated RatingSell (D)
4/23/2026
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
Reiterated RatingBuy
4/22/2026
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
UpgradeHoldStrong-Buy
3/27/2026
AEXA
American Exceptionalism Acquisition
Reiterated RatingSell (E)
(Data available from 6/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AEXA
American Exceptionalism Acquisition
N/AN/AN/AN/A($0.40) per shareN/A
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
N/AN/AN/AN/A$5.14 per shareN/A
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
$448.85M1.34$1.97 per share4.58$13.51 per share0.67
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AEXA
American Exceptionalism Acquisition
-$7.20M$0.06188.03N/AN/AN/AN/AN/AN/A
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
-$134.04M-$2.05N/AN/AN/AN/AN/AN/AN/A
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
-$66.19M-$0.82N/A6.29N/A-11.93%-5.93%-1.04%7/28/2026 (Estimated)
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest RANG, BBOT, ILPT, and AEXA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
N/A$0.05N/A$0.05N/AN/A
5/12/2026Q1 2026
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
N/A-$526.11N/A-$526.11N/AN/A
4/29/2026Q1 2026
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
-$0.20-$0.14+$0.06-$0.14$114.82 million$116.42 million
3/24/2026Q4 2025
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
N/A$0.0650N/A$0.0650N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AEXA
American Exceptionalism Acquisition
N/AN/AN/AN/AN/A
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
N/AN/AN/AN/AN/A
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
$0.202.22%-38.10%N/A N/A
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
N/AN/AN/AN/AN/A

Latest RANG, BBOT, ILPT, and AEXA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/9/2026
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
quarterly$0.053.17%4/21/20264/21/20265/14/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AEXA
American Exceptionalism Acquisition
N/A
20.19
20.19
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
N/A
6.16
6.16
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
4.74
4.24
4.24
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AEXA
American Exceptionalism Acquisition
249.46 millionN/AN/A
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
N/A80.11 million60.56 millionN/A
Industrial Logistics Properties Trust stock logo
ILPT
Industrial Logistics Properties Trust
60066.67 million65.13 millionOptionable
Range Capital Acquisition Corp. stock logo
RANG
Range Capital Acquisition
N/A14.00 million10.42 millionN/A

Recent News About These Companies

Media Sentiment Over Time

Top Headlines

View All Headlines

American Exceptionalism Acquisition NYSE:AEXA

$11.28 -0.02 (-0.16%)
Closing price 06/12/2026 03:59 PM Eastern
Extended Trading
$11.30 +0.02 (+0.14%)
As of 06/12/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

We are led by Chamath Palihapitiya, the founder and Managing Partner of Social Capital. Like Social Capital, the company is formed to confront the world’s hardest problems. Although these problems have evolved over the past decade, our approach remains the same—with a dedication to first principles thinking, deep technological understanding and a willingness to be contrarian to consensus. --- We intend to find companies that operate in sectors that we believe will be instrumental in maintaining U.S. global leadership for the next century. We believe that these innovative sectors are dependent on new company formation, the sustainability of robust private market funding and an increased willingness of private technology companies to become publicly-traded and therefore become available to a broader universe of investors who can benefit from their disruption and growth. Although there are many industries that are critically important in maintaining U.S. global leadership, we intend to focus on four areas that we believe are the most critical for investment and in which we have direct expertise. • Energy Production: Led by reindustrialization, AI, data centers and electrification, the United States has faced a sustained increase in demand for energy for the first time in two decades. In order for the United States to maintain energy independence, we do not believe there is any substitute to an ‘all of the above’ approach to energy production. While fracking and the natural gas revolution have supported the United States to date, we do not believe that this will be sufficient in the coming decades. Scaled solar energy, commercial nuclear energy, enhanced geothermal energy and mining for critical non-fuel minerals that are essential to national and economic security are all areas that will require capital in the coming years to support economic growth. • In this area, Social Capital led a $375 million Series C round in 2021 for Palmetto, a clean energy and technology services platform. In 2024, Palmetto secured more than $1.2 billion in capital to expand LightReach, accelerating solar adoption to an average of 300 new households per day across 30 states, according to a press release issued by Palmetto. • Artificial Intelligence: Venture investment in AI reached a record $130 billion in 2024, as reported in fDi Intelligence, as new language models competed for market share against established incumbents—while incumbents accelerated investment to keep their technological advantages. While the ultimate implications of the AI arms race are unclear, it appears obvious that we are in the early innings of a paradigm change in how technology interacts with day-to-day life. We will look to opportunities in AI technology itself, as well as solutions that solve the defining constraints of compute and technology. • In this area, Social Capital led Groq’s Series A and Series B rounds in 2016 and 2018 to develop custom silicon designed specifically for fast and scalable AI inference. Since then, Groq has raised over $1 billion to deploy its chips known as LPUs in data centers around the world. In addition, Mr. Palihapitiya founded 8090 in 2024 to build an AI-enabled software factory designed to produce high-quality, well-maintained enterprise software and has seen firsthand how AI has the power to fundamentally reshape our relationship with work. • Decentralized Finance: While Mr. Palihapitiya has long been a proponent of Bitcoin as an inflation hedge and alternative to fiat currencies, we believe that the next stage of development is the increased integration between traditional finance and decentralized finance. Recent developments such as the success of the public market debut of Circle Internet Group Inc. (NYSE: CRCL) has demonstrated how decentralized finance can be used to disintermediate traditional finance intermediaries and provide clear value for customers via reduced friction. As adoption accelerates across both consumers and institutions, we believe the opportunities for thoughtful application of decentralized finance are significant. • In this area, as an early investor in Bitcoin and Digital Currency Group, Mr. Palihapitiya has long believed in the power of decentralized finance and blockchain technologies to revolutionize traditional finance. Although the path to mainstream acceptance has taken longer than expected, the expansion of digital assets (including stablecoins) into the mainstream now appears to be inevitable. • Defense: Over the last decade, the U.S. Department of Defense budget requests for procurement and R&D have increased by approximately 340%, reaching $30.6 billion in 2024 from $9 billion in 2015, as reported by the Deloitte Research Center for Energy & Industrials. We believe the defense industry is expected to see continued growth as heightened geopolitical tensions contribute to increases in defense spending, notably in the unmanned systems market. • In this area, Social Capital led a Series A round in 2016 for Saildrone, which is a solution for offshore energy development and protection. Since then, Saildrone has raised over $200 million in funding to scale production and deploy its fleet of wind and solar-powered unmanned surface vehicles (USVs) for applications in climate science, maritime security and ocean mapping. Our executive offices are located Menlo Park, CA.

BridgeBio Oncology Therapeutics stock logo

BridgeBio Oncology Therapeutics NASDAQ:BBOT

$7.75 +0.29 (+3.89%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$7.75 0.00 (0.00%)
As of 06/12/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

We are a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Throughout this prospectus, we will refer to this as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any potential business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business or industry, we intend to focus on healthcare or healthcare related industries, which can benefit from the expertise and capabilities of our management team in order to create long-term shareholder value. Our sponsor is an affiliate of Cormorant, a leading life sciences focused investment firm with over $2 billion in assets under management as of December 31, 2022. Our Chairperson and Chief Executive Officer, Bihua Chen, founded Cormorant and is the managing member of Cormorant. Since its inception in 2013, Cormorant has focused on the healthcare industry and invests, throughout their growth cycle, in companies that discover and develop therapeutic drugs or medical technology. Cormorant is an active life-science investor with investments in over 100 privately held, life science-focused companies over this period. Of these investments, over 50 have completed initial public offerings. Notable successes include Prometheus Biosciences, Inc., Turning Point Therapeutics, Inc., and MyoKardia, Inc., each of which has been acquired for more than $4 billion. Other notable successes include BridgeBio Pharma Inc. and Apellis Pharmaceuticals Inc., each of which is a public company with a market capitalization greater than $1 billion. Our executive offices are located at 200 Clarendon Street, 52nd Floor, Boston, MA.

Industrial Logistics Properties Trust stock logo

Industrial Logistics Properties Trust NASDAQ:ILPT

$9.00 -0.01 (-0.11%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$9.02 +0.03 (+0.28%)
As of 06/12/2026 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Industrial Logistics Properties Trust (Nasdaq: ILPT) is a real estate investment trust, or REIT, focused on owning and leasing high quality distribution and logistics properties. As of December 31, 2023, ILPT's portfolio consisted of 411 properties containing approximately 60 million rentable square feet located in 39 states. Approximately 77% of ILPT's annualized rental revenues as of December 31, 2023 are derived from investment grade tenants, tenants that are subsidiaries of investment grade rated entities or Hawaii land leases. ILPT is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. ILPT is headquartered in Newton, MA.

Range Capital Acquisition stock logo

Range Capital Acquisition NASDAQ:RANG

$10.61 -0.01 (-0.08%)
As of 06/12/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Range Capital Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on July 24, 2024 and is headquartered in New York, NY.